U.S. market Closed. Opens in 1 day 5 hours 46 minutes

LRMR | Larimar Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue311.00K272.00K326.00K155.00K78.00K261.00K188.00K212.00K70.00KN/A
Gross Profit-311.00K-272.00K-326.00K-155.00K-78.00K-261.00K-188.00K-212.00K-70.00KN/A
Operating Expenses41.76M36.53M50.47M42.80M23.21M62.46M53.69M56.91M73.74M35.53M
Selling, General & Admin14.09M12.28M12.07M11.40M2.42M12.93M11.95M17.14M19.12M8.14M
Research & Development27.36M24.25M38.40M31.41M20.79M49.53M41.74M39.77M54.62M27.39M
Other Operating ExpensesN/A1.17M-171.00K322.00K82.00KN/AN/AN/AN/AN/A
Operating Income-41.76M-36.53M-50.47M-42.80M-23.21M-62.72M-53.88M-57.12M-73.81M-35.53M
Other Expenses / Income4.81M1.17M-171.00K322.00K82.00K-246.00K947.00K-1.06M-473.00K-1.04M
Before Tax Income-36.95M-35.35M-50.64M-42.48M-23.13M-62.97M-52.93M-58.18M-74.29M-36.57M
Income Tax ExpensesN/A-1.17M-326.00K-155.00K-93.86K-1.60M-900.00K-300.00K-946.00KN/A
Net Income-36.95M-34.18M-50.31M-42.33M-23.13M-61.37M-52.03M-57.88M-74.29M-36.57M
Interest ExpensesN/AN/AN/AN/AN/AN/A971.00K347.00K806.00K-870.00K
Basic Shares Outstanding43.90M25.76M17.16M11.88M9.21M2.69M2.29M2.27M2.23M2.42M
Diluted Shares Outstanding43.90M25.76M17.16M11.88M9.21M2.69M2.29M2.27M2.23M2.42M
EBITDA-41.45M-35.08M-50.14M-42.65M-23.14M-60.81M-52.58M-57.44M-73.41M-35.53M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-36.95M-35.35M-50.64M-42.48M-23.23M-62.97M-51.96M-57.83M-74.43M-37.44M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙